You are here

Article info

Article menu
XML
Review
Neoadjuvant immunotherapy for non-small cell lung cancer: right drugs, right patient, right time?

Authors

  • Elizabeth Ahern School of Clinical Sciences, Monash University Faculty of Medicine Nursing and Health Sciences, Clayton, Victoria, AustraliaMedical Oncology, Monash Health, Clayton, Victoria, AustraliaImmunology in Cancer and Infection, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia PubMed articlesGoogle scholar articles
  • Ben J Solomon Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • Rina Hui Medical Oncology, Westmead Hospital, Westmead, New South Wales, AustraliaFaculty of Medicine, The University of Sydney, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Nick Pavlakis Faculty of Medicine, The University of Sydney, Sydney, New South Wales, AustraliaMedical Oncology, Royal North Shore Hospital Northern Sydney Cancer Centre, St. Leonards, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Ken O'Byrne Medical Oncology, Princess Alexandra Hospital, Woolloongabba, Queensland, AustraliaSchool of Biomedical Sciences, Queensland University of Technology, Brisbane, Queensland, Australia PubMed articlesGoogle scholar articles
  • Brett G M Hughes Medical Oncology, Royal Brisbane and Women's Hospital, Herston, Queensland, AustraliaFaculty of Medicine, The University of Queensland, Herston, Queensland, AustraliaMedical Oncology, The Prince Charles Hospital, Chermside, Queensland, Australia PubMed articlesGoogle scholar articles

Citation

Ahern E, Solomon BJ, Hui R, et al
Neoadjuvant immunotherapy for non-small cell lung cancer: right drugs, right patient, right time?
Journal for ImmunoTherapy of Cancer 2021;9:e002248. doi: 10.1136/jitc-2020-002248
Online issue publication 
February 24, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.